OneOncology · 1 month ago
Cellular Therapy Program Manager
OneOncology is a leading cancer care organization focused on improving survivorship and lessening the burden of cancer. They are seeking a Cellular Therapy Program Manager to provide strategic direction and operational leadership for cellular therapy services, ensuring quality, patient safety, and program growth.
BiotechnologyHealthcareHealth CareOncology
Responsibilities
Strategic Leadership
Market Positioning and Financial Stewardship
Operational Optimization
Performance Management
Regulatory Compliance & Quality Assurance
Growth and Innovation
Qualification
Required
Bachelor's degree in Nursing, Healthcare Administration, Business, or field
Minimum five (2) years of progressive leadership experience in healthcare management, demonstrating accountability for complex clinical operations and strategic initiatives
Recent experience (within the last 5 years) in infusion services, oncology, or advanced therapies such as Cell and Gene Therapy
1-2 years of experience (within the last 5 years) specifically in Cell Therapy populations
Knowledge of clinical operations, financial authorizations for cellular therapy and infusion services, with experience in relevant healthcare technologies and systems
Proven track record of reliability, dependability, and increasing organizational responsibility
Demonstrated ability to lead and inspire diverse healthcare teams
Strong analytical, problem-solving, organizational, and time-management skills
Excellent verbal and written communication skills for engaging stakeholders across all organizational levels
Strong understanding of transplant and cellular therapy processes, including stem cell mobilization, infusion, and post-transplant surveillance
Familiarity with FACT standards
Preferred
Master's or advanced degree in Healthcare Administration, Pharmacy, Business, or other field
Company
OneOncology
OneOncology is a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the US. It is a sub-organization of General Atlantic.
Funding
Current Stage
Late StageTotal Funding
unknownKey Investors
Cencora
2025-12-12Acquired
2023-04-20Secondary Market
Recent News
Business Wire
2026-02-04
2026-01-05
Company data provided by crunchbase